Regeneron Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING CYTOKINE RELEASE SYNDROME

Last updated:

Abstract:

The present invention provides compositions and methods for treating cancer and inhibiting cytokine release syndrome (CRS). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a CD40 antagonist or a CAR-T cell expressing a CD40 antagonist in combination with a therapeutically effective amount of a CD3 multispecific antigen binding molecule.

Status:
Application
Type:

Utility

Filling date:

28 Jan 2022

Issue date:

28 Jul 2022